AttilioOraziMDProfessor

PubMed

• 2 citations
  TP53 Mutations in Myeloproliferative Neoplasms: Context-Dependent Evaluation of Prognostic Relevance.
  Ayalew Tefferi, Maymona Abdelmagid, Giuseppe G Loscocco, Saubia Fathima, Kebede H Begna
  American Journal of Hematology. 2025-04-01
• Role of allo-HCT in "nonclassical" MPNs and MDS/MPNs: recommendations from the PH&G Committee and the CMWP of the EBMT.
  Nicola Polverelli, Juan Carlos Hernandez-Boluda, Francesco Onida, Carmelo Gurnari, Kavita Raj
  Blood. 2025-03-19
• Evidence-based risk stratification of myeloid neoplasms harboring TP53 mutations.
  Mithun Vinod Shah, Kevin Hung MBBS FRACP FRCPA, Anmol Baranwal, Monika M Kutyna, Aref Al-Kali
  Blood Advances. 2025-03-14

Journal Articles

• Hematopoietic Neoplasms with 9p24/JAK2 Rearrangement: A Multicenter Study  
  Guilin Tang, Daniel A Arber, Elizabeth M Margolskee, Heesun J Rogers, Robert P Hasserjian, Eric D Hsi, Sa A Wang, Wayne Tam, Adam Bagg, Olga Weinberg, Jonathan I Lake,..., Nature

Abstracts/Posters

• Retrospective Study of Incidence and Survival for Patients with Hematologic Malignancies Residing at the U.S./Mexico Border
  Attilio Orazi, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Lectures

• Clinical, Immunophenotypic and Genomic Findings  of Acute Undifferentiated Leukemia and Comparison to AML with Minimal Differentiation: A Study from the Bone Marrow P... 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018